Katie Peng

Katie Peng

Director/Board Member at SCHOLAR ROCK HOLDING CORPORATION

Net worth: 2 M $ as of 31/05/2026

55 year
Health Technology
Consumer Services
Commercial Services

Profile

Katie Peng is currently Independent Director at Scholar Rock Holding Corp.
since 2024, Director at California Life Sciences Association, Independent Director at Adicet Bio, Inc. since 2023, and Chief Commercial Officer at Denali Therapeutics, Inc. since 2021.
Former roles include Senior Vice President & Head-OMNI Business Unit at Genentech, Inc., General Manager at Roche Singapore Pte Ltd. from 2012 to 2015, and General Manager at Roche Products Ltd. (Taiwan) from 2015 to 2017.
Education includes undergraduate studies at the University of California, Berkeley, and an MBA from Kelley School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2026 39,747 ( 0.03% ) 2 M $ 31/05/2026
27/04/2026 368 ( 0% ) 3 426 $ 31/05/2026

Katie Peng active positions

CompaniesPositionStart
DENALI THERAPEUTICS INC. Corporate Officer/Principal 27/09/2021
ADICET BIO, INC. Director/Board Member 10/07/2023
SCHOLAR ROCK HOLDING CORPORATION Director/Board Member 15/02/2024
Director/Board Member -

Former positions of Katie Peng

CompaniesPositionEnd
Roche Products Ltd. (Taiwan)
Chief Executive Officer 01/03/2017
Chief Executive Officer 01/03/2015
Corporate Officer/Principal -
See the detail of Katie Peng's experience

Training of Katie Peng

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

10

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Consumer Services

Health Technology

Roche Products Ltd. (Taiwan)

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!